A major advance in cancer investigation is occurring with the use of nanobodies to reactivate damaged p53. This crucial cancer inhibitor protein is frequently disabled in several forms of cancer, causing uncontrolled https://minibookmarking.com/story22079531/mini-antibodies-reactivate-tumor-suppressor-p53-the-promising-hope-for-tumor-treatment